GFAP and glaucoma: The immunoreactivities of GFAP and GS, the glial cell markers, significantly increased in Müller cells of the damaged area and inner and outer layers of the glaucoma retinas [39], which were markedly attenuated by treatment of ERCMs and PDGF-AB (Figure 4C,D).